Login / Signup

Targeted deep sequencing of cell-free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology.

Soo-Ryum YangKelly L MooneyPaolo LibiranCarol D JonesRohan JoshiHubert D LauHenning StehrGerald J BerryJames L ZehnderSteven R LongChristina S KongChristian A Kunder
Published in: Cancer cytopathology (2019)
cfDNA isolated from serous body cavity fluids represents a promising source of genomic input for targeted NGS.
Keyphrases
  • high grade
  • cancer therapy
  • fine needle aspiration
  • single cell
  • copy number
  • drug delivery
  • gene expression
  • genome wide